Community Health Network - South
Indianapolis, IN
Accepting patients
MagnetisMM-32
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
- Bispecific Antibody
- BCMA
- Randomization
- Phase 3
- Phase 1/2
- Has results